Connect with us

Current

Congratulations, Privacy Just Took A Great Leap Out the Window!

Your Data Is Being Used Without Your Permission And Knowledge

The Voice Of EU | In the heart of technological innovation, the collision between intellectual property rights and the development of cutting-edge AI technologies has sparked a significant legal battle. The New York Times has taken legal action against OpenAI and Microsoft, filing a lawsuit in Manhattan federal court. This legal maneuver aims to address concerns surrounding the unauthorized use of the Times’ content for the training of AI models, alleging copyright infringements that could potentially result in billions of dollars in damages.

READ: HOW YOUR DATA IS BEING USED TO TRAIN A.I.

This legal tussle underlines the escalating tension between technological advancements and the protection of intellectual property. The crux of the lawsuit revolves around OpenAI and Microsoft allegedly utilizing the Times’ proprietary content to advance their own AI technology, directly competing with the publication’s services. The lawsuit suggests that this unauthorized utilization threatens the Times’ ability to offer its distinctive service and impacts its AI innovation, creating a competitive landscape that challenges the publication’s proprietary content.

Amidst the growing digital landscape, media organizations like the Times are confronting a myriad of challenges. The migration of readers to online platforms has significantly impacted traditional media, and the advent of artificial intelligence technology has added another layer of complexity. The legal dispute brings to the forefront the contentious practice of AI companies scraping copyrighted information from online sources, including articles from media organizations, to train their generative AI chatbots. This strategy has attracted substantial investments, rapidly transforming the AI landscape.

Exhibit presented by the New York Times’ legal team of ChatGPT replicating a article after being prompted

The lawsuit highlights instances where OpenAI’s technology, specifically GPT-4, replicated significant portions of Times articles, including in-depth investigative reports. These outputs, alleged by the Times to contain verbatim excerpts from their content, raise concerns about the ethical and legal boundaries of using copyrighted material for AI model training without proper authorization or compensation.

The legal action taken by the Times follows attempts to engage in discussions with Microsoft and OpenAI, aiming to address concerns about the use of its intellectual property. Despite these efforts, negotiations failed to reach a resolution that would ensure fair compensation for the use of the Times’ content while promoting responsible AI development that benefits society.

In the midst of this legal battle, the broader questions surrounding the responsible and ethical utilization of copyrighted material in advancing technological innovations come to the forefront.

The dispute between the Times, OpenAI, and Microsoft serves as a significant case study in navigating the intricate intersection of technological progress and safeguarding intellectual property rights in the digital age.


Culture

‘Mrs. Doubtfire’: The highlights Of Robin Williams’ Role That defined His Artistic Greatness

The highlights Of Robin Williams’ Role That defined His Artistic Greatness

The Voice Of EU | One of the most versatile comedian and actor Robin Williams left an indelible mark on an entire generation throughout the 1990s, evoking both laughter and tears. His portrayal of a strict yet endearing housekeeper in the hit film “Mrs. Doubtfire” (1993) resonated deeply with audiences worldwide, propelling it to resounding success across global boundaries.

Señora Doubtfire Robin Williams
Robin Williams in a scene from ‘Mrs. Doubtfire’ (1993). Archive Photos (20th Century-Fox / Getty Images)

Williams played the role, despite the adversities and addictions that plagued his life at the time, by putting aside the devised script and becoming a master of improvisation during the filming of the movie, which brought in more than €400 million.

In the year of its release it was only outdone by Jurassic Park (€1 billion). This is what its director, also an avowed admirer of the American actor, explained on the occasion of the 30th anniversary of Mrs. Doubtfire’s debut on the big screen: “It took me three months to rewrite the script. I sent it to Robin and he said he loved it.” After Williams’ suicide in 2014, in an interview for Business Insider magazine, Chris Columbus unveils details that were buried 30 years ago.

“Four and a half hours, maybe five,” is the time in which, according to the director, Robin Williams was able to play Mrs. Doubtfire, a characterization for which the film earned the Oscar for Best Makeup. The actor was not comfortable in portraying his role: a father who disguises himself as a housekeeper in order to spend more time with his children after a bitter divorce. For him, it presented a challenge. “We never could shoot two consecutive days of Robin as Mrs. Doubtfire. It was a punishing day for him, so always the next day, we would shoot him as Daniel (the father),” the director of the film reveals three decades after its release.

Comedy is acting out optimism.” — Robin Williams

In between the laughs and moments that are etched in the minds of many, Columbus describes the challenge of keeping actors such as Pierce Brosnan and Sally Field, who played leading roles in the film, from breaking away from the script of their characters while Williams was at his most unrestrainedly creative.

Indeed, according to the director, his boundless energy even created situations where the script supervisor could not keep up, resulting in unrepeatable and spontaneous takes. “None of us knew what he was going to say when he got going and so I wanted a camera on the other actors to get their reactions.” Most of the sequences in the film, and specifically all of those featuring Williams, were the result of an incredible amount of improvisation from the American comedian. “If it were today, we would never end. But back then, we were shooting film so once we were out of film in the camera, we would say to Robin, ‘We’re out of film.’ That happened on several occasions,” recalls Columbus.

“Hey boss, the way I like to work, if you’re up for it, is I’ll give you three or four scripted takes, and then let’s play.” This was the actor’s first warning to the director of Mrs. Doubtfire. Robin Williams was a significant figure in Chris Columbus’ life, and he still is to this day. Not only because he was responsible for his move to San Francisco, the actor didn’t want to shoot anywhere else, but due to his ability to make people laugh and cry at the same time. “Williams wanted the film to be shot there because he was living in San Francisco with his wife, Marsha, and their children. Thanks to him I fell in love with the city that has become my home,” he explains.

“You will have bad times, but they will always wake you up to the stuff you weren’t paying attention to.” — Robin Williams

The director also reminisced about some memorable scenes that contributed to the film’s status as a cinematic masterpiece, as perceived by many. However, what stood out the most was his innate ability to improvise: “The entire restaurant sequence was remarkable. When Robin, portraying Mrs. Doubtfire, accidentally loses his teeth in his drink, you can see the joy on Robin’s face; he’s almost smirking to himself for coming up with that.” Following the success of the Mrs. Doubtfire premiere, the production team is currently exploring ways to honor Williams and his portrayal in the film, although no definitive plans have been made yet. “There are approximately 972 boxes of footage stored in a warehouse somewhere in California. There’s something truly special and enchanting about his performances, and I believe it would be exciting to delve deeper into it.”

Despite initial reservations about creating a sequel, the notion of a new spin-off gained traction shortly before the actor’s tragic passing on August 11, 2014, at his residence in Paradise Bay, California. “Robin’s only concern was: ‘Boss, do I have to spend as much time in the suit this time around?’ The physical toll of portraying Doubtfire was immense for Robin; it felt like running a marathon every day,” the director recounts. Following a brief meeting at the actor’s home, and a simple handshake, Chris Columbus began outlining the script mere days before the unfortunate event. “During the rewrite, we contemplated reducing the role of Doubtfire. However, Robin’s untimely demise extinguished any hopes of a sequel,” he laments. Although not spearheaded by its creator, Mrs. Doubtfire has found new life as a stage musical. “What set him apart as a performer is that there was no one like Robin Williams before him, and there will never be anyone like him again. He was truly one-of-a-kind,” reflects the actor’s superior.

Mrs. DoubtfireRobin Williams and Matthew Lawrence in a scene from ‘Mrs. Doubtfire’ (1993).

In addition to the director, another Mrs. Doubtfire star who later spoke of Robin Williams’ brilliance was Matthew Lawrence, who played Daniel’s son. Lawrence was just a teenager in the film, which also gave a debut to his co-star Mara Wilson, the unforgettable Matilda. One day Lawrence went to Robin’s dressing room and did not expect what he was told: “‘Stay away from drugs, particularly cocaine.’ He was being serious and told me: ‘You know when you come to my trailer and you see me like that?’ He’s like, ‘That’s the reason why. And now I’m fighting for the rest of my life because I spent 10 years doing something very stupid every day. Do not do it.’ I stayed away from it because of him”, Lawrence recalled in an interview with People magazine in March 2022.

The lesser-known chapter of Williams’ life, while unrelated to his demise, shed light on the inner struggles of a comedian committed to bringing joy to others yet grappling with profound personal sorrow. “As charismatic as he appeared on screen, I’d often visit him in his trailer for chats, he was tormented. It was truly agonizing for him. He didn’t conceal it. He confided in me about his battles with addiction,” the actor concluded.


Continue Reading

Culture

Conflicted History: ‘Oppenheimer’ And Its Impact On Los Alamos And New Mexico Downwinders

‘Oppenheimer’ And Its Impact On Los Alamos And New Mexico Downwinders

The Voice Of EU | In the highly anticipated blockbuster movie, “Oppenheimer,” the life of J. Robert Oppenheimer, the man behind the first atomic bomb, is portrayed as a riveting tale of triumph and tragedy.

As the film takes center stage, it also brings to light the often-overlooked impacts on a community living downwind from the top-secret Manhattan Project testing site in southern New Mexico.

A Forgotten Legacy

While the film industry and critics praise “Oppenheimer,” a sense of frustration prevails among the residents of New Mexico’s Tularosa Basin, who continue to grapple with the consequences of the Manhattan Project. Tina Cordova, a cancer survivor and founder of the Tularosa Basin Downwinders Consortium, expresses their feelings, stating, “They invaded our lives and our lands and then they left,” referring to the scientists and military personnel who conducted secret experiments over 200 miles away from their community.

The Consortium, alongside organizations like the Union of Concerned Scientists, has been striving to raise awareness about the impact of the Manhattan Project on New Mexico’s population. Advocates emphasize the necessity of acknowledging the human cost of the Trinity Test, the first atomic blast, and other nuclear weapons activities that have affected countless lives in the state.

The Ongoing Struggle for Recognition

As film enthusiasts celebrate the drama and brilliance of “Oppenheimer,” New Mexico downwinders feel overlooked by both the U.S. government and movie producers. The federal government’s compensation program for radiation exposure still does not include these affected individuals. The government’s selection of the remote and flat Trinity Test Site, without warning residents in the surrounding areas, further added to the controversy.

Living off the land, the rural population in the Tularosa Basin had no idea that the fine ash settling on their homes and fields was a result of the world’s first atomic explosion.

The government initially attempted to cover up the incident, attributing the bright light and rumble to an explosion at a munitions dump. It was only after the U.S. dropped atomic bombs on Japan weeks later that New Mexico residents realized the magnitude of what they had witnessed.

Tracing the Fallout

According to the Manhattan Project National Historical Park, large amounts of radiation were released into the atmosphere during the Trinity Test, with fallout descending over a vast area. Some of the fallout reached as far as the Atlantic Ocean, but the greatest concentration settled approximately 30 miles from the test site.

Now I Am Become Death, the Destroyer of Worlds.

J. Robert Oppenheimer

The consequences of this catastrophic event have affected generations of New Mexicans, who still await recognition and justice for the harm caused by nuclear weapons.

A Tale of Contrasts: Los Alamos and the Legacy of Oppenheimer

As the film’s spotlight shines on the life of J. Robert Oppenheimer, a contrasting narrative unfolds in Los Alamos, more than 200 miles north of the Tularosa Basin. Los Alamos stands as a symbol of Oppenheimer’s legacy, housing one of the nation’s premier national laboratories and boasting the highest percentage of people with doctorate degrees in the U.S.

Oppenheimer’s influence is evident throughout Los Alamos, with a street bearing his name and an IPA named in his honor at a local brewery. The city embraces its scientific legacy, showcasing his handwritten notes and ID card in a museum exhibit. Los Alamos National Laboratory employees played a significant role in the film, contributing as extras and engaging in enlightening discussions during breaks.

The “Oppenheimer” Movie

Director Christopher Nolan’s perspective on the Trinity Test and its profound impact is evident in his approach to “Oppenheimer.” He has described the event as an extraordinary moment in human history and expressed his desire to immerse the audience in the pivotal moment when the button was pushed. Nolan’s dedication to bringing historical accuracy and emotional depth to the screen is evident as he draws inspiration from Kai Bird and Martin J. Sherwin’s Pulitzer Prize-winning book, “American Prometheus: The Triumph and Tragedy of J. Robert Oppenheimer.

For Nolan, Oppenheimer’s story is a potent blend of dreams and nightmares, capturing the complexity and consequences of the Manhattan Project. As the film reaches global audiences, it also offers a unique opportunity to raise awareness about the downwinders in New Mexico, whose lives were forever altered by the legacy of nuclear weapons testing.

The Oppenheimer Festival and Beyond

Los Alamos is determined to use the Oppenheimer Festival as an opportunity to educate visitors about the true stories behind the film’s events. The county’s “Project Oppenheimer” initiative, launched in early 2023, encompasses forums, documentaries, art installations, and exhibits that delve into the scientific contributions of the laboratory and the social implications of the Manhattan Project.

A special area during the festival will facilitate discussions about the movie, fostering a deeper understanding of the community’s history. The county aims to continue revisiting and discussing the legacy of the Manhattan Project, ensuring that the impact of this pivotal moment in history is never forgotten.

As “Oppenheimer” takes audiences on an emotional journey, it serves as a reminder that every historical event carries with it complex and multifaceted implications. The movie may celebrate the scientific achievements of the past, but it also illuminates the urgent need to recognize and address the human cost that persists to this day.


We Can’t Thank You Enough For Your Support!

— By Team VoiceOfEU.com

— For Info.: info@VoiceOfEU.com

— Anonymous Submissions: press@VoiceOfEU.com


Continue Reading

Current

GSK’s Mosquirix Is Revolutionizing The Fight Against Malaria

GSK’s Mosquirix And The Fight Against Malaria

Over the past three years, the global focus has primarily been on the Covid-19 pandemic, diverting attention and resources away from other infectious diseases that disproportionately affect vulnerable populations in the Global South. Among these diseases, malaria continues to be a pressing public health concern, claiming the lives of hundreds of thousands of people each year, especially children in Sub-Saharan Africa. While significant progress has been made in preventing and treating malaria, innovative solutions are needed to combat this deadly disease.

Advancements in Malaria Prevention:

Researchers have made remarkable progress in both prevention and treatment strategies for malaria. The World Health Organization’s recommendation of dual-ingredient insecticide-treated bed nets in March 2023 marks a significant milestone in preventing malaria transmission by Anopheles mosquitoes. These nets, including those with more lethal insecticide combinations and those disrupting mosquito growth, are key tools in malaria prevention efforts.

LEARN MORE: ALL ABOUT HEALTHCARE

The Importance of Cost-Effective Antimalarial Medicines:

Cost-effective antimalarial medicines play a crucial role in combating malaria. In 2021, approximately 45 million children between the ages of three months and five years received seasonal malaria chemoprevention, which involved monthly doses of therapeutic drugs at a cost of less than $4 per person. While this approach has shown promising results, the development of a groundbreaking vaccine brings renewed hope.

GSK’s Mosquirix (RTS,S) Vaccine:

GSK’s Mosquirix, also known as RTS,S, is an innovative vaccine that has the potential to transform the fight against malaria. This vaccine offers hope in preventing the disease, particularly among children in malaria-endemic regions. Although the current cost is relatively high, around $40 per child for the first year, it presents an essential step forward in malaria prevention efforts.

The Persistent Threat of Malaria:

Despite substantial investments of $26 billion to combat malaria in Sub-Saharan Africa, the number of cases has seen a slight increase between 2000 and 2019, although the number of deaths has decreased. This highlights the need for new prevention measures tailored to vulnerable populations, especially children. Taking inspiration from the Covid-19 pandemic, where monoclonal antibodies have demonstrated their potential, similar approaches could be explored in the fight against malaria.

The Potential of Monoclonal Antibodies:

Monoclonal antibodies, laboratory-made copies of immune system proteins, have shown immense potential in combating various diseases, including cancer and autoimmune disorders. Their remarkable selectivity and ability to target specific molecular markers make them an attractive option for preventive interventions. Researchers at the United States National Institutes of Health, led by Robert Seder, have identified two antibodies that target CSP-1, a protein used by the malaria parasite to invade liver cells. Clinical trials are currently underway in Mali and Kenya to assess their safety and efficacy, focusing on seasonal and year-round malaria transmission settings.

Game-Changing Potential:

Monoclonal antibodies have the potential to be a game-changer in malaria prevention, advancing the long-sought goal of eradication. The latest generation of antimalarial antibodies offers extended protection, with a single dose potentially safeguarding a child for at least three months, if not longer. Clinical trials will determine the extent and duration of this protection and guide future improvements to achieve a once-a-year injection.

Making Monoclonal Antibodies Accessible:

While monoclonal antibodies are often associated with high costs, efforts to increase their potency could significantly reduce expenses. It is estimated that an injection as small as one milliliter of the antibody drug being trialed in Mali and Kenya could protect children at a cost of only $5-10 per person. To ensure accessibility, it is crucial to engage national regulatory agencies and involve affected countries in the production of these biologics. While manufacturing antibodies is a complex and regulated process, investing in the necessary technology now would greatly benefit developing economies burdened by endemic malaria.

Addressing Disparities and Raising Awareness:

Currently, demand for monoclonal antibodies primarily comes from high-income countries, with Africa accounting for only 1% of global sales. This disparity underscores the importance of working with national regulatory agencies to address public health concerns and involve affected countries in the production and distribution of these life-saving biologics. Collaboration among government, academia, and industry is crucial to coordinate advocacy efforts and raise awareness about the potential of monoclonal antibodies in malaria prevention.

Preparing for Success:

While the deployment of the first generation of antimalarial antibodies is expected to occur no earlier than 2027, it is essential to start preparing for their potential success now. These antibodies hold tremendous promise as a powerful weapon in the fight against malaria, alongside bed nets, medicines, and emerging vaccines. Clinical trials will provide vital information on the extent of their efficacy, duration of protection, and dosage requirements. It is imperative to remain proactive and ensure that the necessary infrastructure and policies are in place to facilitate the widespread adoption of these breakthrough treatments.

Combining Science & Research:

As the world continues to battle the ongoing Covid-19 pandemic, it is crucial not to overlook the persistent threat of malaria, especially in regions heavily impacted by poverty. While significant progress has been made in malaria prevention and treatment, the development of innovative solutions like GSK’s Mosquirix vaccine and the potential of monoclonal antibodies offer renewed hope in the fight against this deadly disease. By harnessing the lessons learned from Covid-19 research and engaging in collaborative efforts, we can work towards a future where malaria is no longer a major public health concern. Together, we can strive for the eradication of malaria and ensure a healthier future for vulnerable populations worldwide.


By Laura Richardson | Independent Contributor “The Voice Of EU

Thank You For Your Support!

— Compiled by Team VoiceOfEU.com

— For More: info@VoiceOfEU.com

— Anonymous News Submissions: press@VoiceOfEU.com


Continue Reading

Trending

Subscribe To Our Newsletter

Join our mailing list to receive the latest news and updates 
directly on your inbox.

You have Successfully Subscribed!